Fig. 5.
![Fig. 5. Ca2+ responses of HPB.ALL subclones to TR agonists. CD45+ HPB.45.1 cells (□) or CD45-deficient HBP.45.0 cells (▨) were loaded with Indo-1 and stimulated with either 50 nmol/L thrombin or 120 μmol/L TFRIFD, and intracellular [Ca2+] was measured using a spectrofluorimeter. Values represent the mean ± SD of triplicate determinations.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/5/10.1182_blood.v90.5.1893/4/bl_0018f5.jpeg?Expires=1735844073&Signature=HiO2kNzW-isbYW15~0YLeXlPYi31ZmFFaYB5ZOYkcYe9ydq0eHe-PpBxShArEme8gK3R5cEEHa~OWxDH9aAxRcnC--u1PgPrcEW58HZf0i7PxI38n~mG5pFIf~cD0yYiVTDRFV8yaJ1xV-MxcasCuev8K3-uretTuOXro0m1gUof4gJZJQTvqB4BBnnHWX43QnGQZfyAsG68g21ldo7hvlzk2hrJnaBasPQVQt8Pu6rqtIG9QjpGKM5PpC2BvOSM7opcL34FpADpYL2EwDSaeOo66DLwj0r1UnAvHbpxZeee7gSzwi1ui7sjbwSV-WnSppwFgypOLOET6~WBdKe6eA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Ca2+ responses of HPB.ALL subclones to TR agonists. CD45+ HPB.45.1 cells (□) or CD45-deficient HBP.45.0 cells (▨) were loaded with Indo-1 and stimulated with either 50 nmol/L thrombin or 120 μmol/L TFRIFD, and intracellular [Ca2+] was measured using a spectrofluorimeter. Values represent the mean ± SD of triplicate determinations.
